Stealth's rare disease drug falls short in study, sinking shares

·

·

Stealth's rare disease drug falls short in study, sinking shares

A rare disease drug developed by Boston-based Stealth BioTherapeutics missed its goals in a late-stage study, sending shares in the biotech down by about two-thirds Friday and putting at risk a partnership signed in October with Alexion Pharmaceuticals.
See Original Article

Tesla Cybertrucks Are Years Away, But 'Cyberfakes' Are Already Everywhere

Tesla’s new electric pickup truck, the Cybertruck, is hands down the most coveted Christmas gift this holiday season. It’s priced within the range of a regular pickup but offers top-notch performance specs and a stunning retro-futurist appearance. Since its debut …
See Original Article

Twitter Suspends 90000 Accounts Used to Spread Saudi Spam

Twitter Inc. removed almost 90,000 accounts linked to the Saudi Arabian government that researchers identified as part of a sweeping, state-backed
See Original Article

Fixed-Income ETFs Are on Pace for Their Best Year Yet

The ETF industry continues to attractive billions of dollars in new investor money, and many have turned to fixed-income ETFs this year. “If we keep on the trend, it’ll be the best year ever for fixed-income,” Noel Archard, Global Head of SPDR Product, State …
See Original Article

New toilet design aims to cut time in the bathroom

A British company has patented a new toilet design with a sloped seat. Spend too long on it and you’ll get leg cramps. Get the latest from TODAY. Sign up for our newsletter. SUBSCRIBE. Dec. 20, 2019, 2:05 PM PST. By Callie Patteson. People are spending …
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.